Something New about Something Old: A 10-Year Follow-Up on Classical and New Psychoactive Tryptamines and Results of Analysis
Journal of Psychoactive Drugs June 1, 2017 Álvaro José Palma-Conesa, Mireia Ventura, Liliana Galindo et al. 65 citations
New psychoactive tryptamines, which mimic the effects of regulated hallucinogens, pose a potential public health risk. Analysis of 25,296 samples submitted to a harm-reduction organization from 2006 to 2015 identified 436 tryptamines, of which 232 (53.21%) were not regulated. The most common unregulated tryptamine was 4-AcO-DMT, for which no human studies exist. Unregulated tryptamines were more likely to contain a single unadulterated substance. The number of tryptamine samples increased over time, and there were significant differences between client expectations and actual analysis results for regulated versus unregulated groups. Further research is needed to address health risks.